AptarGroup, Inc. with ticker code (ATR) have now 4 confirmed analysts covering the stock with the consensus suggesting a rating of ‘buy’. The target price High/Low ranges between 152 and 125 calculating the mean target price we have $139.75. Given that the stocks previous close was at $127.53 this is indicating there is a potential upside of 9.6%. The 50 day moving average now sits at $125.02 and the 200 day MA is $118.07. The company has a market capitalization of 8.23B. The stock price for the company is currently 125.42 USD
The potential market cap would be $9,021,019,531 based on the market consensus.
The company is not paying dividends at this time.
Other points of data to note are a P/E ratio of 33.18, revenue per share of 51.83 and a 5.73% return on assets.
AptarGroup, Inc. is a designer and manufacturer of a range of drug delivery and consumer product dispensing, sealing and active packaging solutions and services. The Company operates through three segments: Aptar Pharma, Aptar Beauty and Aptar Closures. Aptar Pharma includes operations that sells dispensing systems and sealing solutions and also manufactures and sells elastomeric primary packaging components. The Company’s products include stoppers for infusion, antibiotic, lyophilization and diagnostic vials. The Aptar Beauty segment includes operations that sell dispensing systems, drug delivery systems, sealing solutions and services to the prescription drug, consumer health care, injectables, and active material science solutions markets. The Aptar Closures business serves multiple markets, including food, beverage, personal care, home care, beauty and healthcare. This segment offers food protection business and elastomeric flow-control technology business.
